These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8329829

  • 1. Growth hormone (GH) profiles in response to continuous subcutaneous infusion of GH-releasing hormone(1-29)-NH2 in children with GH deficiency.
    Tauber MT, Pienkowski C, Pigeon P, Cataldi M, Rochiccioli P.
    Acta Paediatr Suppl; 1993 Mar; 388():28-30; discussion 31. PubMed ID: 8329829
    [Abstract] [Full Text] [Related]

  • 2. Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone.
    Neyzi O, Yordam N, Ocal G, Bundak R, Darendeliler F, Açikgöz E, Berberoğlu M, Günöz H, Saka N, Calikoğlu AS.
    Acta Paediatr Suppl; 1993 Mar; 388():16-21; discussion 22. PubMed ID: 8329826
    [Abstract] [Full Text] [Related]

  • 3. A comparative study of growth hormone (GH) and GH-releasing hormone(1-29)-NH2 for stimulation of growth in children with GH deficiency.
    Chen RG, Shen YN, Yei J, Wang CF, Xie DH, Wang XH, Zhou JD, Chen CY, Wu YL, Gunnarsson R.
    Acta Paediatr Suppl; 1993 Mar; 388():32-5; discussion 36. PubMed ID: 8329830
    [Abstract] [Full Text] [Related]

  • 4. Intranasal administration of growth hormone-releasing hormone(1-29)-NH2 in children with growth hormone deficiency: effects on growth hormone secretion and growth.
    Hümmelink R, Sippell WG, Benoit KG, Danielson K, Faijerson Y.
    Acta Paediatr Suppl; 1993 Mar; 388():23-6; discussion 27. PubMed ID: 8329828
    [Abstract] [Full Text] [Related]

  • 5. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL, Stirling HF, Kelnar CJ, Savage MO, Dunger DB, Buckler JM, Shalet SM.
    Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
    [Abstract] [Full Text] [Related]

  • 6. Modification of 24-hour growth hormone secretion after continuous subcutaneous infusion of growth hormone-releasing hormone (GHRH (1-29)NH2) in short children with low 24-hour growth hormone secretion.
    Tauber MT, Pienkowski C, Landier F, Gunnarsson R, Rochiccioli P.
    Acta Paediatr Scand Suppl; 1989 May; 349():117-22; discussion 123-4. PubMed ID: 2546370
    [Abstract] [Full Text] [Related]

  • 7. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
    Massoud AF, Hindmarsh PC, Brook CG.
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
    [Abstract] [Full Text] [Related]

  • 8. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE, Tauber MT, Coude FX, Arnone M, Morre M, Uboldi F, Barbeau C.
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [Abstract] [Full Text] [Related]

  • 9. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E, Imperiale E, Boffano GM, Mazza E, Bellone J, Arvat E, Procopio M, Goffi S, Barreca A, Chiabotto P.
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [Abstract] [Full Text] [Related]

  • 10. Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocity.
    Kirk JM, Trainer PJ, Majrowski WH, Murphy J, Savage MO, Besser GM.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):487-93. PubMed ID: 7955460
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of continuous subcutaneous growth hormone-releasing hormone (GHRH (1-29)NH2) infusions to augment growth hormone secretion and to promote growth.
    Brain C, Hindmarsh PC, Pringle PJ, Brook CG.
    Acta Paediatr Scand Suppl; 1989 Oct; 349():109-13; discussion 123-4. PubMed ID: 2546369
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration.
    Wilton P, Chardet Y, Danielson K, Widlund L, Gunnarsson R.
    Acta Paediatr Suppl; 1993 Mar; 388():10-5. PubMed ID: 8329825
    [Abstract] [Full Text] [Related]

  • 14. The effect of a continuous infusion of a somatostatin analogue (octreotide) for two years on growth hormone secretion and height prediction in tall children.
    Hindmarsh PC, Pringle PJ, Stanhope R, Brook CG.
    Clin Endocrinol (Oxf); 1995 May; 42(5):509-15. PubMed ID: 7621570
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sustained improvement in growth velocity and recovery from suboptimal growth hormone (GH) secretion after treatment with human pituitary GH-releasing hormone-(1-44)-NH2.
    Lifshitz F, Lanes R, Pugliese M, Fort P, Perez I, Puentes S, Cervantes C, Gunczler P, Chasalow FI, Recker B.
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1255-60. PubMed ID: 1430086
    [Abstract] [Full Text] [Related]

  • 17. The use of growth hormone-releasing hormone in the diagnosis and treatment of short stature.
    Grossman A, Savage MO, Blacklay A, Ross RM, Plowman PN, Preece MA, Coy DH, Besser GM.
    Horm Res; 1985 Nov; 22(1-2):52-7. PubMed ID: 2863206
    [Abstract] [Full Text] [Related]

  • 18. Subcutaneous treatment with growth hormone-releasing hormone for short stature.
    Hernández M, Fragoso J, Barrio R, Argente J, Arilla E.
    Horm Res; 1988 Nov; 30(6):252-7. PubMed ID: 2907992
    [Abstract] [Full Text] [Related]

  • 19. Subcutaneous growth hormone-releasing hormone augments pulsatile nocturnal GH release in GH-insufficient children, but may also raise basal GH secretion.
    Ross RJ, Kirk JM, Tsagarakis S, Trainer PJ, Ciccarelli E, Touzel R, Grossman A, Savage MO, Besser GM.
    Clin Endocrinol (Oxf); 1990 Aug; 33(2):239-48. PubMed ID: 2225481
    [Abstract] [Full Text] [Related]

  • 20. Effect of overnight constant infusion of human growth hormone (GH)-releasing hormone-(1-44) on 24-hour GH secretion in children with partial GH deficiency.
    Rochiccioli PE, Tauber MT, Uboldi F, Coude FX, Morre M.
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1100-5. PubMed ID: 3093519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.